respiratori
infect
immunosuppress
patient
account
signific
morbid
mortal
immunosuppress
comorbid
diseas
predispos
patient
pulmonari
infiltr
infecti
noninfecti
aetiolog
exclud
infect
import
order
improv
manag
noninfecti
aetiolog
bronchoscopi
bronchoalveolar
lavag
bal
improv
abil
detect
infect
immunosuppress
patient
time
frequenc
use
often
subject
variabl
institut
polici
patient
ill
undergo
bal
requir
altern
diagnost
strategi
immunosuppress
patient
increas
risk
sever
diseas
respiratori
virus
incid
lower
respiratori
tract
viral
infect
difficult
accur
identifi
vari
diagnost
techniqu
season
geograph
variat
viral
infect
lack
specif
symptom
radiograph
find
fact
mani
virus
difficult
cultur
ex
vivo
multiplex
pcr
test
identifi
respiratori
virus
three
atyp
bacteria
detect
rate
symptomat
lower
respiratori
tract
viral
infect
bal
fluid
report
low
use
cultur
via
pcr
importantli
identif
respiratori
virus
pcr
alway
indic
activ
infect
often
uncertainti
clinic
signific
detect
certain
virus
rhinoviru
lower
respiratori
tract
nasopharyng
np
respiratori
viral
panelpcr
rvppcr
noninvas
detect
viral
infect
spars
data
abil
np
rvppcr
identifi
lower
respiratori
tract
diseas
immunosuppress
patient
two
studi
report
differ
fals
neg
np
rate
patient
compar
patient
mani
clinic
decis
includ
antibiot
choic
whether
pursu
bal
base
initi
np
rvppcr
test
therefor
import
know
test
characterist
np
rvppcr
abil
identifi
lower
respiratori
tract
diseas
studi
aim
better
character
np
rvppcr
comparison
bal
rvppcr
test
determin
posit
neg
predict
valu
sensit
specif
fals
neg
rate
also
determin
whether
clinic
variabl
significantli
associ
posit
bal
rvppcr
well
determin
import
season
variabl
rvppcr
test
final
evalu
whether
addit
pathogen
identifi
bal
fluid
patient
np
test
conduct
retrospect
chart
review
evalu
immunosuppress
adult
underw
bronchoscopi
pulmonari
depart
univers
rochest
medic
center
januari
june
institut
review
board
approv
obtain
patient
includ
pair
np
swab
perform
within
day
prior
bronchoscopi
patient
underw
bal
concern
lower
respiratori
tract
infect
base
imag
symptom
np
bal
sampl
analys
use
filmarray
biofir
diagnost
inc
salt
lake
citi
ut
usa
multiplex
pcr
detect
adenoviru
coronaviru
four
strain
human
metapneumoviru
rhinovirusenteroviru
influenza
three
strain
influenza
b
respiratori
syncyti
viru
b
parainfluenza
mycoplasma
pneumonia
chlamydia
pneumonia
bordetella
pertussi
accept
cultur
pcr
techniqu
perform
microbiolog
laboratori
bacteri
fungal
viral
identif
demograph
clinic
microbiolog
data
collect
characterist
thought
associ
viral
infect
includ
fever
cough
dyspnoea
hypoxia
leucopenia
lymphopenia
ground
glass
opac
imag
oedema
immunosuppress
categori
defin
hivaid
haematolog
malign
solid
organ
transplant
immunosuppress
immunosuppress
chemotherapi
prednison
mg
daili
two
immunosuppress
agent
defin
winter
spring
month
decemb
may
analysi
season
variabl
posit
predict
valu
neg
predict
valu
sensit
specif
fals
neg
rate
calcul
compar
rvppcr
test
np
bal
sampl
linear
logist
regress
analys
perform
determin
whether
associ
exist
clinic
variabl
bal
rvppcr
result
multivari
analys
perform
use
manual
stepwis
addit
independ
variabl
analys
perform
use
sa
version
sa
institut
inc
cari
nc
usa
statist
signific
defin
p
three
hundr
immunosuppress
patient
underw
bronchoscopi
januari
june
eightynin
patient
np
bal
rvppcr
test
radiograph
abnorm
present
patient
seventyeight
patient
either
cough
short
breath
eleven
patient
fever
without
respiratori
symptom
median
durat
time
symptom
onset
np
test
day
rang
day
median
time
durat
np
test
bal
day
rang
day
demograph
clinic
characterist
shown
tabl
seven
differ
viru
strain
identifi
patient
posit
tabl
four
patient
influenza
viru
detect
bal
three
receiv
influenza
vaccin
posit
neg
predict
valu
np
rvppcr
concord
bal
rvppcr
test
respect
tabl
sensit
specif
np
rvppcr
test
respect
fals
neg
rate
np
rvppcr
patient
pair
npbal
rvppcr
test
concord
npposit
balposit
np
bal
pcr
test
fiftyeight
patient
concord
np
bal
rvppcr
test
total
concord
tabl
virus
detect
pcr
list
tabl
patient
characterist
posit
result
list
tabl
ten
patient
discord
test
seven
patient
sampl
np
test
neg
bal
test
posit
np
bal
virus
identifi
bal
test
also
list
tabl
five
patient
haematolog
malign
two
immunosuppress
three
patient
sampl
np
bal
coronaviru
found
twice
rhinoviru
one
patient
haematolog
malign
one
solid
organ
transplant
one
immunosuppress
influenza
miss
np
test
two
patient
receiv
allogen
stem
cell
transplant
one
receiv
influenza
vaccin
prior
bronchoscopi
rapid
influenza
test
check
patient
receiv
vaccin
neg
clinic
variabl
associ
posit
bal
rvppcr
sampl
unadjust
logist
regress
analys
show
allogen
bone
marrow
transplant
test
perform
decemb
may
significantli
associ
increas
odd
posit
viral
bal
rvppcr
ci
ci
respect
tabl
associ
identifi
posit
bal
rvppcr
group
subset
immunosuppress
clinic
variabl
tabl
multivari
logist
regress
analys
demonstr
season
allogen
bone
marrow
transplant
independ
associ
increas
odd
posit
viral
bal
rvppcr
ci
ci
respect
fortynin
patient
pair
rvppcr
test
perform
decemb
may
twentytwo
bal
rvppcr
posit
see
fig
supplementari
inform
test
posit
virus
detect
month
six
neg
np
rvppcr
test
forti
pair
test
perform
june
novemb
six
posit
bal
rvppcr
test
one
patient
neg
np
rvppcr
test
differ
detect
nonvir
organ
found
bal
posit
neg
np
rvppcr
group
p
bacteria
p
fungal
speci
tabl
npposit
group
three
patient
five
bacteri
speci
isol
wherea
npneg
group
five
patient
six
bacteri
speci
isol
patient
posit
np
rvppcr
test
six
patient
fungal
speci
identifi
bal
test
patient
neg
np
rvppcr
test
patient
fungal
speci
identifi
bal
test
immunosuppress
patient
risk
sever
diseas
respiratori
viral
infect
multiplex
pcr
increas
detect
virus
role
manag
immunosuppress
patient
remain
unclear
studi
design
better
character
role
rvppcr
diagnosi
viral
infect
vulner
popul
found
rvppcr
test
np
sampl
high
posit
neg
predict
valu
respect
compar
bal
rvppcr
test
overal
concord
np
bal
rvppcr
test
low
fals
neg
rate
suggest
np
rvppcr
test
suffici
diagnos
exclud
lower
respiratori
tract
viral
infect
could
help
patient
clinic
unstabl
undergo
bronchoscopi
limit
data
compar
posit
multiplex
pcr
test
perform
np
bal
sampl
immunosuppress
patient
hakki
et
al
report
detect
virus
patient
np
bal
np
bal
np
bal
yield
overal
posit
rate
azadeh
et
al
overal
posit
rate
studi
pneumonia
detect
bal
fluid
overal
concord
np
bal
test
report
hakki
et
al
significantli
higher
report
azadeh
et
al
howev
subgroup
immunosuppress
patient
n
report
azadeh
et
al
concord
closer
concord
rate
report
hakki
et
al
data
show
similar
rate
viral
posit
studi
mention
studi
patient
posit
viral
pcr
test
overal
concord
identifi
atyp
bacteria
use
pcr
number
fals
neg
np
rvppcr
test
np
bal
popul
patient
significantli
lower
patient
report
azadeh
et
al
high
fals
neg
rate
may
due
sever
variabl
includ
popul
nonimmunosuppress
patient
poor
swab
handl
techniqu
lower
np
viral
shed
higher
viral
level
lower
respiratori
tract
season
variabl
viru
detect
treatment
neuraminidas
inhibitor
prior
test
influenza
presenc
viral
mutat
major
test
occur
summer
fall
fewer
virus
circul
would
less
chanc
viru
found
bal
use
pcr
test
azadeh
et
al
filmarray
biofir
diagnost
inc
yet
find
similar
hakki
et
al
fals
neg
use
xtag
analys
suggest
brand
pcr
test
necessarili
influenc
rate
pcr
posit
studi
influenza
diagnos
four
time
bal
two
patient
influenza
detect
bal
np
test
azadeh
et
al
also
report
four
patient
influenza
detect
bal
np
test
studi
howev
provid
clinic
demograph
data
patient
two
patient
studi
np
bal
influenza
symptom
less
day
viral
shed
upper
respiratori
tract
present
fals
neg
np
test
could
due
variabl
mention
reason
neg
np
influenza
test
patient
remain
unclear
anoth
import
factor
address
prior
studi
impact
influenza
vaccin
recommend
immunosuppress
patient
influenza
vaccin
could
potenti
explain
lower
rate
viral
shed
thu
fals
neg
np
test
convers
immunosuppress
patient
risk
reduc
immunogen
thu
may
adequ
protect
influenza
infect
three
four
patient
diagnos
influenza
bal
studi
receiv
influenza
vaccin
prior
bronchoscopi
find
would
suggest
high
clinic
suspicion
influenza
maintain
regardless
immun
statu
andor
neg
np
swab
pcr
test
overal
bacteria
fungal
sampl
detect
bal
fluid
patient
np
posit
five
bacteri
speci
identifi
three
patient
six
fungal
speci
identifi
six
patient
patient
np
neg
bacteri
speci
identifi
five
patient
fungal
speci
pneumocysti
identifi
patient
four
np
candida
speci
cultur
exclud
tabl
npposit
group
two
patient
rhinoviru
coronaviru
cultur
cytomegaloviru
npneg
group
three
patient
cytomegaloviru
posit
viral
cultur
two
patient
posit
herp
simplex
type
viral
cultur
candida
speci
thought
patholog
patient
observ
increas
detect
virus
decemb
may
lower
detect
summer
fall
month
winter
np
viral
pcr
test
less
help
rule
viral
infect
five
seven
np
bal
test
perform
sampl
obtain
februari
april
therefor
bronchoscopi
repeat
viral
test
strongli
consid
case
neg
np
rvppcr
test
perform
winter
spring
month
copathogen
common
immunosuppress
patient
pulmonari
infiltr
hakki
et
al
report
six
patient
posit
bal
rvppcr
also
addit
pathogen
detect
five
bacteria
one
galactomannan
suggest
invas
aspergillosi
azadeh
et
al
report
seven
immunosuppress
patient
posit
np
pcr
also
addit
pathogen
detect
bal
sampl
report
eight
patient
posit
np
pcr
test
also
addit
pathogen
isol
bal
sampl
tabl
find
suggest
bronchoscopi
consid
even
patient
posit
rvppcr
np
sampl
data
also
support
use
bronchoscopi
patient
neg
np
rvppcr
test
addit
pathogen
identifi
bal
fluid
acknowledg
studi
limit
inher
observ
studi
small
sampl
size
within
group
limit
statist
power
way
standard
time
sampl
collect
rel
symptom
onset
patient
underw
repeat
test
protocol
institut
time
workup
immunosuppress
patient
pulmonari
infiltr
possibl
np
sampl
collect
adequ
could
contribut
fals
neg
rate
lastli
bal
return
highli
variabl
also
may
affect
viral
pcr
posit
conclus
viral
pcr
test
perform
sampl
obtain
nasopharynx
high
concord
viral
pcr
test
perform
bal
sampl
low
fals
neg
rate
howev
np
test
heavili
reliant
proper
collect
techniqu
variabl
detect
certain
virus
noninvas
test
use
np
rvppcr
use
bronchoscopi
unabl
perform
reliabl
test
diagnos
exclud
viral
infect
reli
neg
predict
valu
np
viral
pcr
patient
low
clinic
suspicion
infect
could
lead
cost
save
avoid
duplic
rvp
test
howev
bal
remain
import
tool
evalu
infiltr
immunosuppress
patient
particularli
winter
spring
month
discord
test
high
rate
coinfect
ultim
accur
time
diagnosi
exclus
viral
infect
via
rvppcr
test
either
np
bal
sampl
like
import
clinic
impact
immunosuppress
patient
rapid
initi
antivir
therapi
care
antibiot
stewardship
